“RAYAT SHIKSHAN SANTHA’S”

YASHAVANTRAO CHAVAN INSTITUTE OF SCIENCE,

SATARA (AUTONOMOUS)
DEPARTMENT OF STATISTICS
INDUSTRY VISIT REPORT

Name: Bebale Arati Chandrakant Roll No.:238

Class: M.Sc II (2021-2022) UID:202097139

Lupin Limited is an Indian multinational pharmaceutical company based in

Mumbai, Maharashtra, India. It is one of the largest generic pharmaceutical companies
by revenue globally. Lupin Limited was found in 1968 by Desh Bandhu Gupta.
Named after the Lupin flower. Because of its inherent qualities and what is personifies
and stands for. Lupin first gained recognition when it become one of the world’s
largest manufactures of tuberculosis drugs. It also has a global leadership position in
the anti-TB and cephaoporin segments. The exact location of this pharmaceutical
industry is Lupin Limited, B/4 Laxmi Towers, Bandra Kurla Complex, Bandra
(E), Mumbai 400050, Maharashtra, India.

Contact of Lupin Limited:

Toll Free 1800-399-2561 (For medical information and product complaint)
Customer Support Email: info@lupin.com
Official website: www.lupin.com

Founder Desh Bandhu Gupta, who was a professor of chemistry at BITS-

Pilani, Rajasthan. After success with Lupin, in 1988 Gupta founded the group's CSR
arm, the Lupin Human Welfare & Research Foundation (LHWRF). In October 2019,
Pharma major lupin limited announced today the Appointment of Sreeji Gopinatham
as Chief Information Officer (CIO). In March 2019, the US FDA put several Lupin
drug plants on notice for quality problems, and indicated it might not approve future
Lupin drug applications.Lupin's research program covers the entire pharma product
chain. The company's R&D program is headquartered in the Lupin Research Park
located near Pune and Aurangabad that houses over 1,400 scientists. Lupin's R&D
covers the Generic Research, Advanced Drug Delivery Systems (ADDS) Research,
Intellectual Property Management, Novel Drug Discovery and Development (NDDD),
Biotechnology Research.
 Comparing calcium supplements from natural coral sources (coral calcium)
with available calcium carbonate (from non-coral sources) and calcium citrate
supplements in healthy volunteers by measuring rise in blood calcium and
bioavailability, post intake of each of the calcium supplements.
The study was an open label, single centric study comparing 5 groups of 9
volunteers each taking different calcium supplements: two arms of coral calcium
supplement tablets of elemental calcium strengths 225 mg and 500mg (Group A, B), 2
arms of non-coral calcium carbonate supplement tablets of elemental calcium
strengths 400mg and 500mg (Group C, D), and one arm of calcium citrate malate
supplement tablets with elemental calcium 250mg (Group E). Baseline fasting blood
and urine samples were taken followed by dosing of the calcium tablet preparation.
Blood and urine samples were thereafter collected at 2, 4, 6, and 10 hours to evaluate
blood calcium levels, bioavailability and urinary calcium excretion.
Calcium from Coral source may show better absorption and bioavailability as
compared to other Calcium supplements containing non coral calcium carbonate and
calcium citrate malate.